GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: B2036-PEG | Somavert®
                                 
                                                         
                            
                            
                            
                                 
                                
                                pegvisomant is an approved drug (FDA (2003), EMA (2008)) 
                                                        
                                                    
                                Compound class: 
                                                            Peptide
                                 
                                
                                    
                                        Comment: Pegvisomant is a PEGylated 191 amino acid protein analogue of growth hormone, with antagonist action at the growth hormone receptor. The peptide sequence can be obtained via the ChEMBL link. PEGylation protects the peptide from proteolytic breakdown and extends its bioactive half-life.
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     |